NovaBridge Biosciences Balance Sheet (2018-2025) | NBP

Balance Sheet Dec2018 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Receivables - Accured 0.22M0.11M0.04M1.04M
Assets
Current Assets
Cash & Equivalents 229.71M161.39M220.81M435.96M718.07M4,341.96M551.13M526.06M451.90M2,359.59M297.42M310.67M79.33M310.67M53.60M68.26M228.06M
Receivables - Net 0.56M1.10M0.55M1.76M4.56M1.44M0.08M3.58M0.74M
Receivables - Other 1.59M2.30M34.31M242.91M4.94M43.46M1.16M1.97M
Receivables 2.85M1.10M0.54M36.07M247.47M6.38M-0.72M4.74M2.72M
Work In Process 34.31M39.69M
Inventory 12.45M4.07M4.63M0.72M
Prepaid Assets 12.87M19.30M18.56M32.38M29.49M200.42M29.85M15.08M11.29M102.34M7.22M-22.67M-4.27M3.29M4.61M2.03M4.50M
Current Assets 294.59M193.14M239.64M472.54M806.32M5,215.73M747.91M644.16M509.90M3,074.84M324.53M230.48M188.21M176.69M173.23M167.64M232.78M
Non-Current Assets
Construction in Progress 3.30M0.87M
Property, Plant & Equipment (Net) 4.00M4.27M3.77M3.98M3.81M22.32M7.15M9.13M8.55M52.58M5.07M0.20M0.19M0.20M0.19M0.17M0.15M
Long-Term Investments 112.38M100.32M578.03M55.07M32.50M4.34M11.41M1.68M30.82M
Goodwill 23.51M23.07M23.01M23.95M24.53M162.57M25.43M24.27M22.86M162.57M
Intangibles 21.53M21.12M21.07M17.97M18.17M120.06M18.72M17.81M16.72M118.50M16.40M
Goodwill & Intangibles 45.04M44.18M44.08M41.11M42.71M282.63M44.15M42.74M39.57M281.07M16.40M
Long-Term Deferred Tax 2.81M2.51M
Other Non-Current Assets 1.04M3.74M3.46M6.13M4.17M2.30M3.51M8.26M8.18M0.46M1.44M1.36M1.29M1.22M1.15M
Non-Current Assets 49.04M53.38M50.34M157.44M122.32M932.29M188.81M102.65M201.39M436.85M209.48M23.35M44.47M35.99M35.71M39.07M44.63M
Assets 343.63M246.53M289.98M633.04M955.73M6,148.01M876.08M745.22M572.77M3,511.70M362.91M253.83M232.68M212.68M208.94M206.71M277.41M
Liabilities
Current Liabilities
Accounts Payables 9.79M38.81M34.40M49.83M84.58M536.16M92.80M-7.33M99.35M595.22M49.69M3.34M11.02M7.64M6.92M6.49M7.38M
Notes Payables 11.57M7.09M2.67M4.16M
Payables 21.36M45.91M34.40M48.88M84.58M536.16M92.80M-7.44M102.01M595.22M53.85M3.34M11.02M7.64M6.92M6.49M7.38M
Accumulated Expenses 8.22M6.11M6.75M2.63M
Other Accumulated Expenses 9.11M4.87M1.44M
Short term Debt 11.57M7.09M2.67M4.16M
Current Leases 0.97M1.16M1.18M1.22M9.90M4.80M6.35M3.37M27.32M3.04M0.74M0.75M0.82M0.83M0.85M0.87M
Current Taxes 9.11M
Current Deferred Revenue 2.05M1.13M1.22M10.56M0.31M
Total Current Liabilities 50.06M83.49M35.56M51.46M86.93M550.62M97.60M88.08M106.60M663.07M57.20M13.97M11.77M8.45M7.75M7.35M16.09M
Non-Current Liabilities
Convertible Debt 9.69M9.68M9.79M9.54M
Non-Current Deffered Revenue 0.36M0.56M35.04M37.66M267.64M40.57M
Preferred Stock Liabilities 421.65M440.42M
Liabilities from Discontinued Operations 50.98M
Operating Leases 1.06M1.03M0.76M0.84M31.25M12.79M-2.59M4.51M20.41M6.25M3.22M-0.41M3.07M2.85M-0.40M2.40M
Non-Current Deferred Tax Liability 2.81M2.51M
Other Non-Current Liabilities 1.33M1.24M1.35M6.20M2.34M-0.15M2.39M49.00M9.68M-0.11M-0.11M-0.11M
Total Non-Current Liabilities 47.48M79.18M1.65M682.12M27.60M145.82M32.63M1,015.91M48.59M17.30M14.90M11.63M
Total Liabilities 60.12M94.79M48.81M81.95M106.63M688.32M162.92M145.64M163.63M1,064.91M124.28M17.19M14.80M11.52M10.60M9.97M18.50M
Shareholder's Equity
Total Debt 11.57M7.09M2.67M4.16M
Common Equity -138.14M-288.68M241.17M849.10M5,459.69M713.16M4,016.07M409.14M2,446.78M238.63M236.63M217.88M201.16M198.34M196.73M
Shareholder's Equity -138.14M-288.68M551.08M849.10M713.16M599.59M409.14M238.63M201.16M196.73M258.92M
Liabilities and Shareholders Equity 343.63M246.53M289.98M620.98M955.73M6,148.01M876.08M756.96M572.77M3,511.70M362.91M253.83M232.68M212.68M208.94M206.71M277.41M
Treasury Shares 0.17M0.58M0.62M0.23M0.23M1.48M0.41M
Retained Earnings -146.73M-353.88M-435.53M-451.40M-305.30M-3099.77M-681.14M-806.45M-964.85M-7634.95M-1156.63M-1256.47M-1276.98M-1286.04M-1289.19M-1294.69M-1301.52M
Shares Outstanding 1.21M1.19M24.88M28.75M27.07M26.95M194.07M